Answers are grounded in this paper and cite their sources.
Background: variants or delayed syndromic onset may obscure these indicators, leading to misdiagnosis as ITP and unnecessary immunosuppression. Objectives: This study prospectively evaluated a multiparameter platelet size trigger as an accessible screening entry point for early MYH9-RD recognition, independent of a family history, treatment refractoriness, or syndromic features. Methods: ), with subsequent confirmation by immunofluorescence. Results: variants in the coiled-coil domain, supported by blood smear findings (including giant platelets and neutrophil inclusions), bioinformatics assessment, and structural-modeling data. All 7 patients were diagnosed within 1 month following the screening, avoiding unnecessary ITP-directed therapy. The composite trigger (mean platelet volume, platelet-large cell ratio, and smear-based morphology) provided higher diagnostic yield than any single parameter alone. Conclusion: This streamlined 3-step strategy provides a practical, potentially resource-conscious pathway for early MYH9-RD diagnosis, 1 better aligned with current clinical practice in China than the existing diagnostic paradigms.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: